Raymond James Financial Inc. Takes $3.18 Million Position in Perrigo Company plc (NYSE:PRGO)

Raymond James Financial Inc. bought a new position in shares of Perrigo Company plc (NYSE:PRGO - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 123,553 shares of the company's stock, valued at approximately $3,177,000. Raymond James Financial Inc. owned approximately 0.09% of Perrigo as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Versant Capital Management Inc acquired a new stake in shares of Perrigo in the fourth quarter worth $45,000. GAMMA Investing LLC increased its holdings in Perrigo by 93.7% in the 4th quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock valued at $49,000 after purchasing an additional 929 shares in the last quarter. Central Pacific Bank Trust Division raised its position in Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after purchasing an additional 500 shares during the period. Venturi Wealth Management LLC lifted its stake in shares of Perrigo by 97.8% during the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company's stock worth $108,000 after purchasing an additional 2,084 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of Perrigo in the fourth quarter worth about $149,000. Hedge funds and other institutional investors own 95.91% of the company's stock.

Perrigo Stock Up 0.0 %

PRGO traded up $0.01 on Monday, reaching $28.07. The company's stock had a trading volume of 1,305,986 shares, compared to its average volume of 1,497,975. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46. The business's 50 day moving average is $26.19 and its 200 day moving average is $26.16. The stock has a market cap of $3.83 billion, a price-to-earnings ratio of -23.99 and a beta of 0.48.

Remove Ads

Perrigo (NYSE:PRGO - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share for the quarter, topping analysts' consensus estimates of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The business had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.20 billion. As a group, research analysts forecast that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were given a dividend of $0.29 per share. This is a boost from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.16 annualized dividend and a dividend yield of 4.13%. Perrigo's dividend payout ratio (DPR) is presently -92.80%.

Insider Activity at Perrigo

In related news, EVP Ronald Craig Janish sold 7,800 shares of the firm's stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the transaction, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on PRGO shares. StockNews.com downgraded Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Argus lowered shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Finally, Piper Sandler downgraded shares of Perrigo from an "overweight" rating to a "neutral" rating and decreased their target price for the company from $34.00 to $27.00 in a research note on Monday, January 6th. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $33.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.